WhereDaily News: PURE Bioscience Board Reduces to Five Members
SAN DIEGO, CA--(Marketwired - Apr 14, 2014) - PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced the resignation of Craig C. Culver from its Board of Directors. Culver also served as Chairman of the Company's Compensation Committee. Culver informed the Company with regret that based on a significant increase in the level of his primary business activities he would not be able to meet the appropriate fiduciary oversight and governance duties required as a board member for PURE.